BCYC Bicycle Therapeutics plc
Fundamentals / CIK 0001761612 / USDBicycle Therapeutics plc reported $83.53M in revenue and a net loss of $141.8M for the trailing twelve months ended September 30, 2026 (up 190.2% year over year), with a -189.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BCYC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$83.53M +190.2% YoY
-
Operating Income TTM-$158.2M -189.4% margin
-
Net Income TTM-$141.8M -169.8% net margin
-
Diluted EPS TTM-$2.03 Split-adjusted
-
Free Cash Flow TTM-$177.0M -211.9% FCF margin
-
Cash & ST Investments Sep 30, 2026$469.9M Total debt: $14.68M
Annual revenue and net income
9 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.59M | $35.27M | $26.98M | $14.46M | $11.70M | $10.39M | $13.80M | $7.14M | $2.06M |
| Research & Development | $240.3M | $173.0M | $156.5M | $81.61M | $44.88M | $33.15M | $25.54M | $20.76M | $11.87M |
| Total Operating Expenses | $319.7M | $245.1M | $216.9M | $131.1M | $77.31M | $62.35M | $40.10M | $28.88M | $18.27M |
| Operating Income | -$247.1M | -$209.9M | -$189.9M | -$116.7M | -$65.62M | -$51.96M | -$26.30M | -$21.75M | -$16.21M |
| EBITDA | -$240.6M | -$202.7M | -$183.4M | -$113.0M | -$64.21M | -$50.68M | -$25.34M | -$21.03M | -$15.88M |
| Interest Expense | $206K | $1.73M | $3.26M | $3.34M | $2.98M | $457K | -- | -- | -- |
| Income Before Tax | -$218.8M | -$173.8M | -$179.2M | -$114.2M | -$68.48M | -$51.73M | -$30.86M | -$22.24M | -$16.28M |
| Income Tax Expense | $152K | -$4.76M | $1.46M | -$1.52M | -$1.66M | -$724K | -$254K | -$396K | -$23K |
| Net Income | -$219.0M | -$169.0M | -$180.7M | -$112.7M | -$66.82M | -$51.01M | -$30.61M | -$21.85M | -$16.26M |
| Basic EPS | -$3.16 | -$2.90 | -$5.08 | -$3.80 | -$2.67 | -$2.66 | -$2.77 | -$49.78 | -$48.81 |
| Diluted EPS | -$3.16 | -$2.90 | -$5.08 | -$3.80 | -$2.67 | -$2.66 | -$2.77 | -$49.78 | -$48.81 |
| Basic Shares Outstanding | 69.3M | 58.2M | 35.6M | 29.7M | 25.1M | 19.1M | 11.0M | 438.9K | 333.1K |
| Diluted Shares Outstanding | 69.3M | 58.2M | 35.6M | 29.7M | 25.1M | 19.1M | 11.0M | 438.9K | 333.1K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.06M | $629K | $887K | $47.95M | $11.73M | $2.92M | $9.98M | $3.71M |
| Research & Development | $33.42M | $41.16M | $48.90M | $51.77M | $58.43M | $71.03M | $59.06M | $49.78M |
| Total Operating Expenses | $47.53M | $55.19M | $66.37M | $72.66M | $77.28M | $89.52M | $80.18M | $71.37M |
| Operating Income | -$13.48M | -$54.56M | -$65.48M | -$24.71M | -$65.55M | -$86.60M | -$70.20M | -$67.66M |
| EBITDA | -$12.40M | -$53.49M | -$64.35M | -$23.37M | -$63.80M | -$84.91M | -$68.57M | -$65.96M |
| Interest Expense | $45K | $44K | $48K | $57K | $44K | $54K | $51K | $52K |
| Income Before Tax | -$9.31M | -$50.24M | -$60.65M | -$18.89M | -$58.90M | -$79.18M | -$61.84M | -$52.94M |
| Income Tax Expense | $1.17M | $90K | $172K | $1.26M | $205K | -$231K | -$1.09M | -$1.08M |
| Net Income | -$10.48M | -$50.33M | -$60.83M | -$20.15M | -$59.10M | -$78.95M | -$60.75M | -$51.85M |
| Basic EPS | -$0.15 | -$0.72 | -$0.87 | -- | -$0.85 | -$1.14 | -$0.88 | -- |
| Diluted EPS | -$0.15 | -$0.72 | -$0.87 | -- | -$0.85 | -$1.14 | -$0.88 | -- |
| Basic Shares Outstanding | 70.0M | 69.8M | 69.7M | -- | 69.3M | 69.3M | 69.2M | -- |
| Diluted Shares Outstanding | 70.0M | 69.8M | 69.7M | -- | 69.3M | 69.3M | 69.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $628.1M | $879.5M | $526.4M | $339.2M | $438.7M | $0 | $0 | $0 |
| Cash & Short-Term Investments | $628.1M | $879.5M | $526.4M | $339.2M | $438.7M | $0 | $0 | $0 |
| Accounts Receivable, Net | $0 | $0 | $0 | $2.04M | $1.00M | $5.46M | $201K | $5.02M |
| Total Current Assets | $682.9M | $928.6M | $561.9M | $369.4M | $458.6M | $155.7M | $104.1M | $76.77M |
| Property, Plant & Equipment, Net | $6.02M | $9.52M | $14.52M | $19.11M | $3.12M | $2.32M | $2.29M | $1.82M |
| Other Non-Current Assets | $12.80M | $11.07M | $5.79M | $8.46M | $3.45M | $1.82M | $1.70M | $3.04M |
| Total Non-Current Assets | $34.71M | $28.26M | $33.48M | $41.23M | $21.24M | $5.43M | $6.05M | $4.86M |
| Total Assets | $717.6M | $956.9M | $595.3M | $410.6M | $479.8M | $161.2M | $110.2M | $81.63M |
| Accounts Payable | $9.67M | $15.79M | $13.05M | $6.47M | $2.72M | $1.36M | $1.95M | $1.89M |
| Deferred Revenue (Current) | $2.96M | $10.19M | $24.98M | $20.42M | $19.27M | $10.13M | $728K | $10K |
| Other Current Liabilities | $136K | $297K | $257K | $1.47M | $570K | $208K | $67K | $99K |
| Total Current Liabilities | $56.98M | $67.23M | $69.54M | $53.34M | $36.24M | $23.13M | $8.82M | $8.93M |
| Long-Term Debt | -- | -- | $30.70M | $30.32M | $29.87M | $14.51M | -- | -- |
| Deferred Revenue (Non-Current) | $35.51M | $91.47M | $110.2M | $41.45M | $52.07M | $25.02M | $4.93M | $14.62M |
| Other Non-Current Liabilities | $1.03M | $1.12M | $4.58M | $3.83M | $3.28M | $2.61M | $2.00M | $897K |
| Total Non-Current Liabilities | $50.64M | $96.58M | $154.9M | $86.48M | $97.30M | $42.56M | $8.18M | $20.33M |
| Total Liabilities | $107.6M | $163.8M | $224.4M | $139.8M | $133.5M | $65.69M | $17.00M | $29.25M |
| Total Debt (incl. Leases) | $17.55M | $10.32M | $44.96M | $44.33M | $44.34M | $15.78M | $1.89M | -- |
| Common Stock | $894K | $890K | $550K | $387K | $384K | $266K | $227K | $10K |
| Retained Earnings | -$899.8M | -$680.8M | -$511.8M | -$331.1M | -$218.4M | -$151.6M | -$100.5M | -$69.94M |
| Accumulated Other Comp. Income | -$3.50M | $119K | -$1.30M | $387K | -$3.39M | -$3.19M | -$1.53M | -$1.75M |
| Total Stockholders' Equity | $610.0M | $793.1M | $370.9M | $270.8M | $346.3M | $95.46M | $93.20M | -$69.83M |
| Total Equity | $610.0M | $793.1M | $370.9M | $270.8M | $346.3M | $95.46M | $93.20M | -$69.83M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $469.9M | $510.1M | $559.5M | $628.1M | $648.3M | $721.5M | $793.0M | $879.5M |
| Cash & Short-Term Investments | $469.9M | $510.1M | $559.5M | $628.1M | $648.3M | $721.5M | $793.0M | $879.5M |
| Accounts Receivable, Net | -- | -- | -- | $0 | -- | -- | $136K | $0 |
| Total Current Assets | $537.6M | $575.2M | $619.1M | $682.9M | $738.8M | $804.3M | $856.1M | $928.6M |
| Property, Plant & Equipment, Net | $4.21M | $4.70M | $5.73M | $6.02M | $6.86M | $8.31M | $8.74M | $9.52M |
| Other Non-Current Assets | $11.98M | $12.67M | $12.99M | $12.80M | $13.71M | $13.81M | $12.36M | $11.07M |
| Total Non-Current Assets | $29.62M | $31.34M | $33.26M | $34.71M | $25.14M | $27.92M | $27.81M | $28.26M |
| Total Assets | $567.2M | $606.6M | $652.4M | $717.6M | $764.0M | $832.2M | $883.9M | $956.9M |
| Accounts Payable | $9.59M | $5.66M | $5.97M | $9.67M | $12.65M | $18.26M | $11.11M | $15.79M |
| Deferred Revenue (Current) | -- | $2.88M | $2.79M | $2.96M | $12.26M | $14.62M | $12.52M | $10.19M |
| Other Current Liabilities | $586K | $160K | $483K | $136K | $204K | $236K | $309K | $297K |
| Total Current Liabilities | $44.46M | $47.63M | $48.89M | $56.98M | $69.28M | $77.42M | $57.62M | $67.23M |
| Deferred Revenue (Non-Current) | $3.69M | $34.08M | $34.34M | $35.51M | $74.12M | $82.94M | $82.21M | $91.47M |
| Other Non-Current Liabilities | $887K | $931K | $973K | $1.03M | $1.09M | $1.14M | $1.12M | $1.12M |
| Total Non-Current Liabilities | $17.44M | $48.69M | $49.19M | $50.64M | $76.19M | $85.85M | $85.94M | $96.58M |
| Total Liabilities | $61.90M | $96.32M | $98.08M | $107.6M | $145.5M | $163.3M | $143.6M | $163.8M |
| Total Debt (incl. Leases) | $14.68M | $15.21M | $15.94M | $17.55M | $6.48M | $7.99M | $9.12M | $10.32M |
| Common Stock | $903K | $900K | $899K | $894K | $894K | $893K | $892K | $890K |
| Retained Earnings | -$1.02B | -$1.01B | -$960.6M | -$899.8M | -$879.6M | -$820.5M | -$741.5M | -$680.8M |
| Accumulated Other Comp. Income | -$5.34M | -$5.42M | -$5.28M | -$3.50M | -$3.47M | -$3.36M | -$1.46M | $119K |
| Total Stockholders' Equity | $505.3M | $510.3M | $554.3M | $610.0M | $618.5M | $668.9M | $740.3M | $793.1M |
| Total Equity | $505.3M | $510.3M | $554.3M | $610.0M | $618.5M | $668.9M | $740.3M | $793.1M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$219.0M | -$169.0M | -$180.7M | -$112.7M | -$66.82M | -$51.01M | -$30.61M | -$21.85M | -$16.26M |
| Depreciation & Amortization | $6.42M | $7.17M | $6.55M | $3.69M | $1.41M | $1.28M | $960K | $712K | $332K |
| Stock-Based Compensation | $39.46M | $38.08M | $32.48M | $26.78M | $12.08M | $6.51M | $3.08M | $1.02M | $515K |
| Change in Receivables | -- | -- | $2.48M | -$1.64M | $4.54M | -$2.15M | $4.91M | -$400K | -- |
| Change in Payables | -$6.87M | $3.10M | $8.00M | $2.56M | $1.20M | -$663K | $220K | -$169K | $67K |
| Operating Cash Flow | -$249.7M | -$164.7M | -$60.63M | -$86.11M | -$14.79M | -$17.79M | -$28.61M | -$26.08M | -$1.42M |
| Capital Expenditure | -$2.35M | -$1.24M | -$2.93M | -$18.99M | -$2.03M | -$1.20M | -$1.55M | -$1.19M | -$1.11M |
| Free Cash Flow | -$252.0M | -$166.0M | -$63.56M | -$105.1M | -$16.82M | -$18.99M | -$30.17M | -$27.26M | -$2.53M |
| Investing Cash Flow | -$2.35M | -$1.24M | -$2.93M | -$18.99M | -$2.03M | -$1.20M | -$1.55M | -$1.19M | -$1.11M |
| Common Stock Issued | -- | $544.1M | $249.3M | $5.70M | $291.0M | $48.14M | -- | -- | -- |
| Financing Cash Flow | -$131K | $519.8M | $250.0M | $6.69M | $320.7M | $62.84M | $58.44M | $25.43M | $57.88M |
| Net Change in Cash | -$251.4M | $353.1M | $187.8M | -$99.53M | $302.7M | $43.87M | $28.74M | -$4.28M | $58.26M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$10.48M | -$50.33M | -$60.83M | -$20.15M | -$59.10M | -$78.95M | -$60.75M | -$51.85M |
| Depreciation & Amortization | $1.07M | $1.07M | $1.13M | $1.34M | $1.76M | $1.70M | $1.63M | $1.70M |
| Stock-Based Compensation | $5.42M | $6.40M | $6.93M | $11.65M | $8.77M | $9.44M | $9.61M | $10.33M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -$133K | -- |
| Change in Payables | $3.68M | -$59K | -$3.84M | -$2.88M | -$5.07M | $6.10M | -$5.02M | $10.69M |
| Operating Cash Flow | -$40.30M | -$49.61M | -$65.92M | -$19.35M | -$71.17M | -$72.79M | -$86.37M | -$9.40M |
| Capital Expenditure | -$305K | -$265K | -$713K | -$574K | -$674K | -$498K | -$604K | -$368K |
| Free Cash Flow | -$40.61M | -$49.87M | -$66.64M | -$19.92M | -$71.85M | -$73.28M | -$86.97M | -$9.76M |
| Investing Cash Flow | -$305K | -$265K | -$713K | -$574K | -$674K | -$498K | -$604K | -$368K |
| Financing Cash Flow | -$31K | -$50K | -$54K | -$15K | -$30K | -$45K | -$41K | $203K |
| Net Change in Cash | -$40.12M | -$49.97M | -$68.64M | -$20.16M | -$73.13M | -$71.52M | -$86.55M | -$11.34M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -340.4% | -595.0% | -704.1% | -806.6% | -561.0% | -500.1% | -190.6% | -304.7% | -787.0% |
| Net Profit Margin | -301.7% | -479.2% | -669.7% | -779.3% | -571.2% | -491.0% | -221.8% | -306.1% | -789.3% |
| Return on Equity (ROE) | -35.9% | -21.3% | -48.7% | -41.6% | -19.3% | -53.4% | -32.8% | -- | -- |
| Return on Assets (ROA) | -30.5% | -17.7% | -30.3% | -27.5% | -13.9% | -31.7% | -27.8% | -26.8% | -- |
| Current Ratio | 11.98x | 13.81x | 8.08x | 6.92x | 12.65x | 6.73x | 11.81x | 8.60x | -- |
| Quick Ratio | 11.02x | 13.08x | 7.57x | 6.40x | 12.13x | 0.24x | 0.02x | 0.56x | -- |
| Debt to Equity | 0.03x | 0.01x | 0.12x | 0.16x | 0.13x | 0.17x | 0.02x | -- | -- |
| Revenue Growth (YoY) | +105.8% | +30.8% | +86.5% | +23.6% | +12.6% | -24.7% | +93.4% | +246.4% | -- |
| 5Y Revenue / Share Growth | +93.1% | -51.5% | -95.3% | -92.1% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -189.4% | -343.6% | -381.7% | -340.4% | -1023.4% | -1495.3% | -965.6% | -595.0% |
| Net Profit Margin | -169.8% | -311.1% | -345.0% | -301.7% | -884.5% | -1257.0% | -790.1% | -479.2% |
| Return on Equity (ROE) | -28.1% | -37.3% | -39.5% | -35.9% | -40.5% | -36.2% | -27.5% | -21.3% |
| Return on Assets (ROA) | -25.0% | -31.4% | -33.6% | -30.5% | -32.8% | -29.1% | -23.0% | -17.7% |
| Current Ratio | 12.09x | 12.08x | 12.66x | 11.98x | 10.66x | 10.39x | 14.86x | 13.81x |
| Quick Ratio | 10.57x | 10.71x | 11.44x | 11.02x | 9.36x | 9.32x | 13.76x | 13.08x |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.01x | 0.01x | 0.01x | 0.01x |
| Revenue Growth (YoY) | +190.2% | -78.5% | -91.1% | +1193.3% | +338.5% | -68.8% | -48.9% | -30.4% |